Keywords: Hikma, CellTrion, Algeria, Biosimilars, Al Dar Al Arabia, MENA region
Hikma expands its manufacturing capabilities in Algeria taking full control of JV; signs biosimilars deal with CellTrion
Article | 13 April 2010
Jordanian-owned Hikma Pharmaceuticals says that its wholly-owned subsidiary, Arab Pharmaceutical Manufacturing Company (APM), has signed an agreement to acquire the 50% ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Negative US patent ruling for Novo Nordisk on Prandin
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Daiichi Sankyo files for Japanese approval of Prasugrel
